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Summary 21 
Pleural effusions (PE) reportedly occur most commonly secondary to bacterial pneumonia with 22 
neoplastic effusions contributing a minority of cases. The majority of reports originate from America 23 
and Australia, where long distance transport of horses, a recognised risk factor, may occur more 24 
frequently than in the United Kingdom (UK). Anecdotally, a greater proportion of horses with PE are 25 
diagnosed with neoplasia in the UK than has been reported. The aim of this retrospective study was 26 
to describe the causes of PE in horses in the UK, and to identify markers that can help differentiate 27 
between septic and neoplastic causes of PE. Medical records from 4 equine hospitals in the UK were 28 
searched for horses diagnosed with PE. Information recorded included signalment, admission 29 
physical examination and biochemical findings, and characteristics of the effusion (volume, cell 30 
count, total protein (TP) concentration). A total of 69 horses were identified, with 26 (38%) 31 
diagnosed with a neoplastic effusion. The remainder were categorized as septic, including 14/43 32 
(32.5%) that had a history of international transport. Horses with septic effusions were significantly 33 
younger (8 vs 13 years; P=0.001) and had significantly smaller volumes of pleural fluid drained at 34 
admission (9.8l vs 32.2l; P<0.001). Horses with septic PE had a significantly higher rectal temperature 35 
(38.6 vs 38.2°C; P=0.03), fibrinogen concentration (7.8g/l vs 5.3g/l; P=0.01) and serum amyloid A 36 
concentration (230mg/l vs 59mg/l; P=0.02) than those with neoplastic effusions. A significantly 37 
higher pleural fluid cell count and TP concentration was identified in horses with septic PE 38 
(63.9x109/l vs 8.6x109/l; P<0.001; 57.5g/l vs 35.9g/l; P=0.04). These results suggest that in the UK 39 
neoplastic effusions account for a greater proportion of PE than previously reported. A large volume 40 
of PE in an older horse with a low cell count and relatively low TP concentration should increase the 41 
index of suspicion of neoplasia. 42 
 43 
 44 
Introduction 45 
The majority of cases of pleural effusion reported in the scientific literature describe horses with 46 
septic pleuropneumonia, resulting from extension of bacterial infection of the lungs in to the pleural 47 
cavity, and most of these studies originate from the United States or Australia. (Smith 1977; Raphel 48 
and Beech 1982; Sweeney 1992; Collins et al 1994; Austin et al 1995; Racklyeft et al 2000; Arroyo et 49 
al 2015) In the United Kingdom, however, a greater proportion of pleural effusion cases seem to be 50 
caused by neoplasia, although the evidence to support this is scarce.  (Mair et al 2004; Mair 2012) 51 
Early determination of the cause of a pleural effusion is paramount, so that prompt and appropriate 52 
treatment can be instigated in cases amenable to treatment, or euthanasia be performed in cases 53 
with a hopeless prognosis. The aim of this study was thus to determine whether horses identified 54 
with pleural effusion and which are resident in the UK are more frequently diagnosed with neoplasia 55 
than has been reported in previous studies, and to determine whether factors present at admission 56 
could be used to increase the index of suspicion for a neoplastic pleural effusion. 57 
 58 
Methods 59 
Records of horses presented to four equine referral hospitals in the United Kingdom between 2000 60 
and 2014 were searched for horses in which a pleural effusion had been diagnosed. The cause of the 61 
effusion was then categorised as either neoplastic, septic or ‘other’ based on information in the 62 
medical records including history, analysis of pleural fluid and tracheal wash characteristics, 63 
ultrasonographic and radiographic findings, and post mortem results as applicable. A history of 64 
travel prior to the development of clinical signs was recorded, as was admission clinical and 65 
clinicopathological data, and outcome. Outcome was recorded as survival to discharge.  Clinical data 66 
recorded included signalment, admission heart rate, respiratory rate and rectal temperature, clinical 67 
signs and duration of those signs prior to admission, and volume of pleural fluid drained at 68 
admission. Clinicopathological data included admission packed cell volume, total plasma protein 69 
concentration, serum amyloid A and fibrinogen concentrations, pleural fluid nucleated cell count 70 
(NCC) and total protein concentration, results of cytological examination of pleural fluid, and 71 
bacterial culture results of tracheal wash samples, pleural fluid or both. When a sample was 72 
obtained from both sides of the thorax, the mean protein and nucleated cell count was used for 73 
statistical comparisons.  Normality of continuous data was assessed utilising the Kolmogorov-74 
Smirnov statistic, and differences between categories compared as appropriate. No cases of pleural 75 
effusion due to ‘other’ reasons were identified and thus differences between septic and neoplastic 76 
pleural effusions were compared using either the independent t test or the Mann Whitney U test. 77 
For all tests, the null hypothesis was rejected when P<0.05. 78 
Results 79 
A total of 69 horses with pleural effusions were identified. Not all data was available for all horses. 80 
The horses ranged in age from 1-28 years (n=56; median 10.5 years, interquartile range (IQR) 10 81 
years) and included a variety of breeds, with the largest single group being Thoroughbreds or 82 
Thoroughbred crosses. (24/65; 38%)  There were 33 geldings, 23 mares and 5 intact males.. Clinical 83 
signs present at admission were recorded for the majority of horses, and were similar for horses 84 
with either neoplasia or septic causes of effusion. The most common signs included increased 85 
respiratory rate (greater than 15/minute) and/or effort (59/64), tachycardia (heart rate greater than 86 
44 beats per minute; 56/64), depressed mentation (42/59), nasal discharge (27/59), lethargy 87 
(21/59), pyrexia greater than 38.5°C (31/62), cough (15/59) and weight loss (15/59). Peripheral 88 
masses or lymphadenopathy were only identified in 2 horses. The duration of clinical signs was 89 
recorded in 40 horses, and ranged from 1 day to 6 months. (median 7 days)  90 
A diagnosis of neoplasia was made in 26/69 (38%) of horses. A definitive diagnosis was made in 23 of 91 
these; the diagnosis was made in 12 horses at post mortem examination and in 11 via cytological 92 
analysis of pleural fluid. In an additional 3 horses a presumptive diagnosis of neoplasia was made.  In 93 
one of these three horses, thoracic radiographs revealed multifocal rounded radiodense lesions 94 
throughout the lungs and the mediastinum, although cytological or histological confirmation was not 95 
pursued. In the second, a mediastinal mass was identified via ultrasonography, and in the third, 96 
masses within the kidney and pelvic cavity were identified via ultrasonography, in addition to 2 97 
masses within the lungs evident on thoracic radiographs. Lymphoma was diagnosed in 11 horses, 98 
unspecified carcinoma in 3, mesothelioma in 3, melanoma in 2 and for 7 horses a specific type of 99 
neoplasia was not confirmed.   100 
Forty three horses were diagnosed with pleural effusions caused by septic causes. Within this 101 
category, 17/43 (39.5%) had a history of international travel; 5 horses had travelled from Ireland to 102 
the UK, 5 from mainland Europe to the UK, 3 from Argentina to the UK, 1 from New Zealand to the 103 
UK. In an additional 3 horses a history of travel was documented but no details provided as to the 104 
duration or distance. For horses with no history of travel, other risk factors identified included 105 
general anaesthesia (n=1) and oesophageal disorders (intra-luminal obstruction n=2; extra-luminal 106 
compressive mass n=1; oesophageal rupture n=2).  107 
Table 1 shows admission clinical and clinicopathologic findings. Horses with neoplastic effusions 108 
were significantly older (median 13 years vs 8 years; P=0.001), had a significantly lower rectal 109 
temperature (mean 38.2°C vs 38.6°C; P=0.04), and lower acute phase protein concentrations (serum 110 
amyloid A: median 59mg/l vs 230mg/l, P=0.02; fibrinogen mean: 5.3g/l vs 7.8g/l, P=0.01) versus 111 
horses with septic pleural effusions. No significant differences in heart rate, respiratory rate, packed 112 
cell volume or total plasma protein concentration were identified between horses with neoplastic vs 113 
septic effusions. 114 
Pleural fluid analysis was performed in 48 horses. The NCC and total protein concentration of the 115 
pleural fluid were both significantly lower in horses with neoplastic effusions compared to septic 116 
effusions (median NCC 8.6 +/-15.3x109/l vs 63.9 +/- 68x109/l; P<0.001; median total protein 117 
concentration 35.9 +/-16.9g/l vs 57.5 +/- 43g/l; P=0.04). The mean volume of pleural fluid drained at 118 
admission was significantly greater in horses with neoplasia (32.2 +/-17.9l) than those with septic 119 
effusions (9.8 +/-7.6l; P<0.001).  120 
Bacterial culture of either tracheal wash samples, pleural fluid aspirates or both was performed in 34 121 
cases with a final diagnosis of septic pleural effusion. No growth was obtained in 6/34 (17.6%), a 122 
single isolate was obtained in 10/34 cases (29%) and a mixed bacterial population in 18/34 (52.9%). 123 
The most common isolates were Streptococcus spp. (16 isolates), Escherichia coli (12), Enterococcus 124 
faecalis (6) and anaerobes (6; including Bacteroides spp (3), Fusobacterium necrophorum (2) and 125 
Clostridium perfringens (1)). Other isolates included Actinobacillus spp, Corynebacterium spp and 126 
Klebsiella spp (all single isolates).    127 
Details of diagnostic imaging results, including radiographic and ultrasonographic findings, were not 128 
recorded in sufficient detail in most cases to allow for meaningful analysis. For example, the 129 
presence or absence of pleural fluid on ultrasonographic examination was noted, but 130 
characterisation of pulmonary parenchymal changes, fibrin accumulation or presence of gas bubbles 131 
within pleural fluid was not consistently reported. 132 
Outcome was recorded as survival to discharge. Overall, there were 43 non-survivors, 24 survivors 133 
and 2 horses in which outcome was not recorded. For horses with septic pleural effusions, survival 134 
rate was 47.6% (20/42). All horses with septic pleural effusions secondary to an oesophageal 135 
disorder died or were euthanased. Six horses with neoplastic effusions were discharged from the 136 
hospital, presumably for either palliative treatment or euthanasia at home, although this was not 137 
recorded.  138 
 139 
Discussion  140 
The findings of this study support the clinical impression that in the UK, pleural effusions secondary 141 
to neoplasia occur relatively more frequently than has been previously described in reports from 142 
other countries. Although direct comparisons are difficult due to differing study designs, one similar 143 
study from the United States of America reported neoplasia as a cause of pleural effusion in only 144 
11% of 37 horses. (Smith 1977) A second study, also from the USA, identified 32/122 (26%) of horses 145 
with effusion caused by ‘non-infectious’ causes, although these were not further categorised. 146 
(Raphel and Beech 1982) Long distance transport is a recognised risk factor for the development of 147 
pleuropneumonia and septic pleural effusion. (Raphel and Beech 1982; Austin et al 1995)  Head 148 
elevation during transportation minimizes a horse’s ability to clear lower respiratory tract (LRT) 149 
secretions and inhaled bacteria. (Norton et al 2013) Combined with the physiologic stress associated 150 
with travelling, the defence mechanisms of the LRT such as mucociliary transport, pulmonary 151 
alveolar macrophages and neutrophils can become overwhelmed. (Smith 1996; Oikawa et al 1995; 152 
Norton et al 2013)  Establishment of infection within the lungs results in increased capillary 153 
permeability of the inflamed lung and visceral pleura, resulting in the accumulation of a sterile 154 
transudate within the pleural cavity. Bacteria from the infected lung rapidly invade the pleural space, 155 
resulting in the accumulation of a large volume of fluid packed with inflammatory cells, cellular 156 
debris and bacteria. (Oikawa et al 1995; Reuss and Giguère 2015)  Most studies define long distance 157 
transport as over 500 miles, and as such, it is possible that the relatively short distances that horses 158 
travel within the UK, as compared to countries like the USA and Australia, may contribute to the 159 
lower proportion of septic pleural effusions. Interestingly, in the current study, 40.5% of horses with 160 
septic pleural effusions had a history of long distance travel (in 14/17, known international 161 
transport) in comparison to 24.4% reported by Raphel and Beech (1982). Thus, long distance 162 
transport is a consistent risk factor for the development of pleuropneumonia, regardless of 163 
geographic location.  164 
In this study, horses with neoplasia were significantly older than those with septic pleural effusions. 165 
Horses with pleuropneumonia are typically young, with mean ages of 3.6 years and 2.5 years in 2 166 
studies. (Collins et al 1994; Arroyo et al 2015) Presumably, this is associated with an increased 167 
likelihood for younger horses to be transported long distances for competitive reasons, or to 168 
undertake high intensity exercise. In the current study, horses with septic pleural effusions were 169 
older than in other reports with a median age of 8 years, suggesting that age in itself may not be a 170 
specific risk factor, more that factors which increase the risk of developing septic pleural effusions 171 
are more likely to occur in younger horses. Whilst horses with neoplasia were older than those with 172 
septic pleural effusions in the current study, neoplasia can affect any age of horse. (Taintor and 173 
Schleis 2011) Lymphoma is typically identified in horses aged 4-10 years, with a mean age of 7 years 174 
in one study (Mair et al 1985; Taintor and Schleis 2011) As such, although there was a statistically 175 
significant difference between the age of both groups, young age in itself should not be relied on to 176 
rule out neoplasia as a cause of pleural effusion. 177 
Consistent with previous reports, neoplasia in this study was associated with large volume 178 
accumulation of pleural fluid, with up to 55l drained in several horses. (Figure 1) (Mair et al 1985; 179 
Mair et al 2004) The development of such large volume effusions is presumed to occur due to 180 
decreased lymphatic drainage, especially when mediastinal masses are present, and/or to increased 181 
fluid production, when the neoplasm affects the pleural surfaces. (De Heer et al 2002; Mair et al 182 
2004) In most horses with neoplasia in the current report, the pleural fluid was described as a 183 
modified transudate, with a relatively low NCC and moderately increased total protein 184 
concentration. As would be expected, both the NCC and the total protein concentration were 185 
significantly higher in horses with septic causes of pleural effusion.  186 
 187 
A definitive diagnosis of neoplasia can be made if cytologic evaluation of the fluid identifies 188 
neoplastic cells or if masses are accessible for biopsy.  (Figures 2 and 3) (Sweeney and Gillette 1989; 189 
Mair et al 2004) Lymphoma is believed commonly to result in exfoliation of neoplastic cells into the 190 
pleural fluid and in two reports up to 40% of cases were diagnosed ante-mortem via cytologic 191 
analysis of pleural fluid. (Mair et al 2004; Lee et al 2013) Similarly, in the current study, a diagnosis of 192 
neoplasia was made in 38% of horses via cytologic examination of pleural fluid. As has been 193 
previously described, most cases in the current series did not present with a peripheral 194 
lymphadenopathy or visible mass that would be amenable to biopsy for histological analysis. (Mair 195 
et al 2004) A recent report described biopsy of intrathoracic masses in 2 horses via thoracoscopy, 196 
allowing the authors to confirm a diagnosis of neoplasia in each case, suggesting that in selected 197 
cases, this may be an appropriate and effective diagnostic tool. (Lee et al 2013)  198 
The prognosis for horses with septic pleural effusion in the current series was relatively poor, with 199 
only 47% of horses surviving to discharge. From the records available, it was not possible to 200 
determine whether horses were euthanased due to poor prognosis and failure to respond to 201 
treatment, or whether euthanasia was elected for financial reasons. Previous reports have similarly 202 
identified overall survival rates of approximately 50% (Racklyeft et al 2000) although more recent 203 
reports suggest that with early identification and treatment, outcomes can be much improved.  204 
(Arroyo et al 2015; Tomlinson et al 2015) Factors associated with failure to survive in previous 205 
studies have included infection caused by anaerobic bacteria, a larger volume of pleural fluid and the 206 
presence of fibrinous effusions. (Figures 4 and 5) (Sweeney et al 1991; Racklyeft and Love 2000; 207 
Tomlinson et al 2015) Anaerobic bacteria were only identified in 6 horses in the current study, 208 
making correlations between their presence and survival difficult to interpret. Consistency in 209 
reporting fibrinous effusions precluded analysis of this characteristic. Pleural fluid drainage (as 210 
compared to thoracocentesis for sampling) was only performed in 13 horses with septic PE; although 211 
not recorded, it may be that, in the remaining horses, the volume of effusion did not warrant 212 
drainage, although this is a presumption as accurate measurements of ultrasonographic dimensions 213 
of visible pleural fluid were not recorded in most cases.  In the current report, all cases with septic 214 
effusions secondary to oesophageal disorders did not survive. Two horses developed aspiration 215 
pneumonia secondary to oesophageal obstruction, two developed oesophageal rupture of unknown 216 
cause, and one had an extra-luminal mass compressing the oesophagus, resulting in aspiration. Five 217 
cases of intrathoracic oesophageal perforations with resultant septic pleural effusions have recently 218 
been reported, all with a similarly grave outcome. (Hepworth-Warren et al 2015)   Aspiration of feed 219 
material and subsequent pneumonia following oesophageal obstruction was not reported in 60 220 
horses treated in a primary care setting. (Duncanson 2006) In comparison, 8/34 horses presented to 221 
a referral hospital developed pneumonia, which was significantly associated with duration of clinical 222 
signs. (Feige et al 2000) Interestingly, the degree of feed material contamination of the trachea 223 
(assessed endoscopically) was not associated with the development of pneumonia, suggesting that 224 
this may not be a sensitive tool in the assessment of whether aspiration has occurred or not. 225 
Considering the poor outcome in horses with oesophageal disorders, close monitoring of animals 226 
with oesophageal obstruction, and prompt evaluation and treatment of those suspected of having 227 
aspiration is warranted. (Feige et al 2000) 228 
This study is limited by its retrospective nature; not all data was available for all horses. A definitive 229 
diagnosis of the type of neoplasia was not obtained in all horses, making a more detailed assessment 230 
of characteristics of individual tumour types impossible. Survival was based solely on survival to 231 
hospital discharge, which is likely to have skewed the data as several horses with neoplasia were 232 
classified as survivors due to the fact that they went home, presumably for euthanasia or palliative 233 
therapy. Although successful treatment of thoracic neoplasia has been reported, the prognosis is still 234 
considered hopeless. (Mair et al 2004; Saulez et al 2004)  235 
Pleural effusions can develop for a number of reasons, the two most common being 236 
pleuropneumonia (septic) and neoplasia. In this study, horses with septic pleural effusions were 237 
younger than those with neoplasia, had significantly higher acute phase protein concentrations at 238 
admission, and had a smaller volume of pleural effusion with a higher NCC and total protein 239 
concentration. Of the 26 horses with confirmed or suspected neoplasia, the diagnosis was confirmed 240 
at post mortem in 12 horses, although in some cases a high index of suspicion existed without 241 
confirmation via cytological analysis of pleural fluid or lymph node aspirate. In 11 horses, a diagnosis 242 
was made ante-mortem using cytological analysis of pleural fluid, and in 3 horses, masses evident on 243 
ultrasound or radiography were consistent with neoplasia but cytological confirmation was not 244 
pursued. This information may be helpful in making a prompt diagnosis when the clinician is 245 
presented with a horse with pleural effusion.  246 
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  313 
Table 1: Clinical and clinicopathologic findings in horses with septic and neoplastic pleural 314 
effusion. amedian (Interquartile range (IQR));  bmean (standard deviation) *Significant difference 315 
between septic and neoplastic groups 316 
PARAMETER SEPTIC GROUP NEOPLASTIC GROUP P 
Agea 
 (years; n=55) 
8 
(9) 
13  
(12) 
0.001* 
Heart Ratea  
(bpm; n=64) 
56 
(15) 
60  
(16) 
0.8 
Respiratory ratea  
(/min; n=65) 
29 
(21) 
36  
(21) 
0.9 
Temperatureb 
(°C; n=63) 
38.6  
(0.89) 
38.2  
(0.74) 
0.04* 
Packed cell volumeb 
(%; n=67) 
36.5  
(11.8) 
36.9 
(12.2) 
0.9 
Total plasma protein 
concentrationb 
(g/l; 62) 
66.8 
(11.95) 
63.71  
(17.99) 
0.4 
Fibrinogen concentrationb  
(g/l; n=56) 
7.8  
(3.3) 
5.3  
(2.9) 
0.01* 
Serum amyloid A 
concentrationb  
(mg/l; n=49) 
230  
(200) 
59  
(238) 
0.02* 
Total volume of pleural fluidb  
(l; n=28) 
9.8 
(7.6) 
32.2 
(17.9) 
<0.001* 
Pleural fluid nucleated cell 
counta (x109/l; n=48) 
63.9 
(68.0) 
8.6 
(15.3) 
<0.001* 
Pleural fluid total protein 
concentrationa (g/l; n=47) 
57.5 
(43.0) 
35.9 
(16.9) 
0.04* 
 317 
  318 
Figure 1: Large volume effusion drained from the pleural cavity of a horse with lymphoma. 319 
 320 
  321 
Figure 2: Histopathology from a lymph node obtained at post mortem examination in a horse with 322 
lymphoma. Sheets of immature and mitotically active lymphomatous cells are noted throughout the 323 
section. 324 
 325 
 326 
  327 
Figure 3: Pleural effusion from a horse with neoplasia, identifying large round cells with eccentric 328 
nucleus. 329 
 330 
  331 
Figure 4: Ultrasonographic image of a horse with fibrinous pleuropneumonia. 332 
 333 
  334 
Figure 5: Post mortem image of horse with severe fibrinous pleuropneumonia, markedly worse on 335 
the left. 336 
 337 
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